Washington Capital Management’s Globus Medical GMED Stock Holding History

Washington Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$741K	Sell	8,600 -1,400	-14%	-$126K	0.63%	40
2025 Q4	$873K	Buy	10,000 +1,900	+23%	+$144K	0.71%	32
2025 Q3	$464K	Buy	8,100 +2,400	+42%	+$138K	0.33%	86
2025 Q2	$336K	Buy	+5,700	New	+$368K	0.25%	102
2024 Q3	–	Sell	-10,400	Closed	-$712K	–	115
2024 Q2	$712K	Hold	10,400	–	–	0.6%	45
2024 Q1	$558K	Hold	10,400	–	–	0.45%	74
2023 Q4	$554K	Buy	+10,400	New	+$507K	0.47%	69
2022 Q4	–	Sell	-4,700	Closed	-$280K	–	107
2022 Q3	$280K	Buy	+4,700	New	+$283K	0.28%	97
2020 Q1	–	Sell	-10,350	Closed	-$609K	–	97
2019 Q4	$609K	Hold	10,350	–	–	0.52%	43
2019 Q3	$529K	Buy	10,350 +2,100	+25%	+$100K	0.52%	48
2019 Q2	$349K	Buy	8,250 +2,350	+40%	+$102K	0.4%	78
2019 Q1	$292K	Buy	+5,900	New	+$267K	0.33%	92

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Washington Capital Management's GMED Position: Q1 2026 in Review

Washington Capital Management reduced its Globus Medical (GMED) stake by 14% in Q1 2026, selling an estimated $126K and leaving 8,600 shares worth $741K. The position accounts for 0.63% of the portfolio, ranked #40.

Washington Capital Management first reported a position in GMED in Q1 2019 and has held it in 12 quarters since. The position peaked at $873K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Washington Capital Management held 8,600 shares of Globus Medical worth $741K as of Q1 2026.
Washington Capital Management sold 1,400 Globus Medical shares in Q1 2026, an estimated $126K.
Globus Medical made up 0.63% of Washington Capital Management's portfolio in Q1 2026, its #40 holding.
Washington Capital Management first reported a position in Globus Medical in Q1 2019 and has held it in 12 quarters since.
Washington Capital Management's Globus Medical position peaked at $873K in Q4 2025.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Washington Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.